Concepedia

Robert L. Walsky

RL

28

Publications

3.3K

Citations

24

H-Index

1993

Active since

Affiliations

Pfizer (United States)(Current)

La Roche College

Eisai (United States)

Vertex Pharmaceuticals (United States)

Eli Lilly (United States)

Robert L. Walsky is an author at Pfizer (United States) specializing in medicine, biochemistry, and pharmacology.

Top concepts

Publications per year

1993–2020

28

Publications

28

VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES

Robert L. Walsky, R. Scott Obach · Drug Metabolism and Disposition · 2004 · 501 citations

Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug Interactions

R. Scott Obach, Robert L. Walsky, Karthik Venkatakrishnan · Drug Metabolism and Disposition · 2006 · 454 citations

The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions

R. Scott Obach, Robert L. Walsky, Karthik Venkatakrishnan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 434 citations

Examination of 209 Drugs for Inhibition of Cytochrome P450 2C8

Robert L. Walsky, Emily A. Gaman, R. Scott Obach · The Journal of Clinical Pharmacology · 2004 · 185 citations

, , +15

SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST

Robert L. Walsky, R. Scott Obach, Emily A. Gaman et al. · Drug Metabolism and Disposition · 2004 · 161 citations

Rows per page

1–5 of 28